Department of Pharmacy and Pharmacology


Senior Lecturer

5 West 2.18



Dr William Tillett

Research interests

Williams current research interests centre on the assessment of psoriatic arthritis (clinical, radiographic and patient reported outcome), early detection of disease and treatment strategies.


Dr William Tillett is a consultant rheumatologist at the Royal National Hospital for Rheumatic Diseases and senior lecturer in the Department of Pharmacy & Pharmacology. He graduated from the University of Bristol with a BSc in Anatomical Science before undertaking his medical degree at the same institution. He undertook his doctoral fellowship in outcome measurement in psoriatic arthritis.

William is the principle investigator or chief investigator on a variety of clinical and commercial trials and investigator initiated studies. Key impacts over the last five years have been the case for improved outcome with early detection of psoriatic arthritis, development and validation of clinical and radiographic measures of disease and understanding the real world effect medical treatment on outcomes important to patients.

William co-authored the 2013 BSR psoriatic arthritis anti-TNF guidelines and currently co-chairs the Psoriatic Arthritis Outcome Measurement in Rheumatology (OMERACT) working group.

He was awarded a EULAR Clinical Scientist award in 2015 for his work assessing the effect of pharmacological treatment of Psoriatic Arthritis.

William is a member of the international Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and is a trustee for the Bath Institute for Rheumatic Diseases (BIRD). 


Read publications by William Tillett

View more publications »